441 related articles for article (PubMed ID: 28753426)
41. SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation.
Fahey CC; Davis IJ
Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28159833
[TBL] [Abstract][Full Text] [Related]
42. Altered expression of interferon-stimulated genes is strongly associated with therapeutic outcomes in hepatitis B virus infection.
Han M; Li Y; Wu W; Zhang Y; Yan W; Luo X; Ning Q
Antiviral Res; 2017 Nov; 147():75-85. PubMed ID: 28988797
[TBL] [Abstract][Full Text] [Related]
43. Structural and enzymatic evidence for the methylation of the ACK1 tyrosine kinase by the histone lysine methyltransferase SETD2.
Le Coadou L; Berthelet J; Mechaly AE; Michail C; Bui LC; Dairou J; Haouz A; Dupret JM; Rodrigues Lima F
Biochem Biophys Res Commun; 2024 Feb; 695():149400. PubMed ID: 38160530
[TBL] [Abstract][Full Text] [Related]
44. Anti-hepatitis B virus activity and mechanisms of recombinant human serum albumin-interferon-alpha-2b fusion protein in vitro and in vivo.
Bingfa X; Qinglin F; Hui H; Canjun W; Wei W; Lihua S
Pharmacology; 2009; 83(6):323-32. PubMed ID: 19407486
[TBL] [Abstract][Full Text] [Related]
45. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
46. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
[TBL] [Abstract][Full Text] [Related]
47. STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha.
Sarkis PT; Ying S; Xu R; Yu XF
J Immunol; 2006 Oct; 177(7):4530-40. PubMed ID: 16982890
[TBL] [Abstract][Full Text] [Related]
48. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production.
Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q
Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391
[TBL] [Abstract][Full Text] [Related]
49. Human metapneumovirus inhibits IFN-alpha signaling through inhibition of STAT1 phosphorylation.
Dinwiddie DL; Harrod KS
Am J Respir Cell Mol Biol; 2008 Jun; 38(6):661-70. PubMed ID: 18218993
[TBL] [Abstract][Full Text] [Related]
50. [ISGF3, a critical factor of the IFN-alpha pathway in the antiviral action of HBV].
Zhang Q; Wei L; Wang Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):110-3. PubMed ID: 16027772
[TBL] [Abstract][Full Text] [Related]
51. An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes.
Furutani Y; Toguchi M; Shiozaki-Sato Y; Qin XY; Ebisui E; Higuchi S; Sudoh M; Suzuki H; Takahashi N; Watashi K; Wakita T; Kakeya H; Kojima S
PLoS One; 2019; 14(6):e0216139. PubMed ID: 31188831
[TBL] [Abstract][Full Text] [Related]
52. VAMP8 Contributes to the TRIM6-Mediated Type I Interferon Antiviral Response during West Nile Virus Infection.
van Tol S; Atkins C; Bharaj P; Johnson KN; Hage A; Freiberg AN; Rajsbaum R
J Virol; 2020 Jan; 94(2):. PubMed ID: 31694946
[TBL] [Abstract][Full Text] [Related]
53. H3K36 trimethylation mediated by SETD2 regulates the fate of bone marrow mesenchymal stem cells.
Wang L; Niu N; Li L; Shao R; Ouyang H; Zou W
PLoS Biol; 2018 Nov; 16(11):e2006522. PubMed ID: 30422989
[TBL] [Abstract][Full Text] [Related]
54. Downregulated NDR1 protein kinase inhibits innate immune response by initiating an miR146a-STAT1 feedback loop.
Liu Z; Qin Q; Wu C; Li H; Shou J; Yang Y; Gu M; Ma C; Lin W; Zou Y; Zhang Y; Ma F; Sun J; Wang X
Nat Commun; 2018 Jul; 9(1):2789. PubMed ID: 30018336
[TBL] [Abstract][Full Text] [Related]
55. Histone methyltransferase protein SETD2 interacts with p53 and selectively regulates its downstream genes.
Xie P; Tian C; An L; Nie J; Lu K; Xing G; Zhang L; He F
Cell Signal; 2008 Sep; 20(9):1671-8. PubMed ID: 18585004
[TBL] [Abstract][Full Text] [Related]
56. SETD2 reduction adversely affects the development of mouse early embryos.
Li C; Huang Z; Gu L
J Cell Biochem; 2020 Jan; 121(1):797-803. PubMed ID: 31407364
[TBL] [Abstract][Full Text] [Related]
57. The methyltransferase NSD3 promotes antiviral innate immunity via direct lysine methylation of IRF3.
Wang C; Wang Q; Xu X; Xie B; Zhao Y; Li N; Cao X
J Exp Med; 2017 Dec; 214(12):3597-3610. PubMed ID: 29101251
[TBL] [Abstract][Full Text] [Related]
58. NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT.
Nakshatri H; Appaiah HN; Anjanappa M; Gilley D; Tanaka H; Badve S; Crooks PA; Mathews W; Sweeney C; Bhat-Nakshatri P
Cell Death Dis; 2015 Jan; 6(1):e1608. PubMed ID: 25611383
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis B Virus-Induced Imbalance of Inflammatory and Antiviral Signaling by Differential Phosphorylation of STAT1 in Human Monocytes.
Song H; Tan G; Yang Y; Cui A; Li H; Li T; Wu Z; Yang M; Lv G; Chi X; Niu J; Zhu K; Crispe IN; Su L; Tu Z
J Immunol; 2019 Apr; 202(8):2266-2275. PubMed ID: 30842274
[TBL] [Abstract][Full Text] [Related]
60. Kinetic characterization of human histone H3 lysine 36 methyltransferases, ASH1L and SETD2.
Eram MS; Kuznetsova E; Li F; Lima-Fernandes E; Kennedy S; Chau I; Arrowsmith CH; Schapira M; Vedadi M
Biochim Biophys Acta; 2015 Sep; 1850(9):1842-8. PubMed ID: 26002201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]